Delivery Order SPE2DB22D3501-SPE2DB24FWS85

Award Date 8/21/24
Potential Completion Date 8/22/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,143,520 units of the medication Tamsulosin Hydrochloride 0.4 mg capsules. The contract has a firm fixed price of $4,060.14 and a period of performance through May 6, 2025. This contract is not set aside and represents open competition. AmerisourceBergen Drug Corp holds a larger...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of 1,000 units of the drug Tamsulosin Hydrochloride 0.4 mg capsules. The contract has a firm fixed price of $1,791.90 and a period of performance through March 26, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,893.35 firm fixed price contract is for the delivery of 1,000 capsules of the medication Tamsulosin Hydrochloride 0.4 mg. The contract has an ultimate completion date of January 29, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,999.92, is for the delivery of 1,000 units of Tamsulosin HCL 0.4 mg capsules to support federal healthcare programs. The contract has a firm fixed price pricing type and a period of performance through January 17, 2024. There is no set-aside designation for this award. AmerisourceBergen...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of Tamsulosin Hydrochloride 0.4 mg capsules in quantities of 1,000 capsules. The contract has a firm fixed price of $2,533.91 and a completion date of September 11, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug Corporation is a for-profit organization that holds several...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,191.64, is for the delivery of 1,000 units of the prescription medication Tamsulosin Hydrochloride 0.4 mg capsules. The contract has an ultimate completion date of March 6, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 1,000 units of the medication Tamsulosin Hydrochloride 0.4 mg Capsules. The $2,051.99 contract has an ultimate completion date of June 12, 2025. AmerisourceBergen Drug Corp holds a large $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which enables the company to supply a wide range of...
This is a firm-fixed price delivery order contract worth $9,139.98 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 1,000 units of Tamsulosin HCl 0.4 mg capsules. The contract has an ultimate completion date of March 6, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as the primary vehicle for providing...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 1,000 units of the prescription drug Tamsulosin Hydrochloride 0.4 mg capsules. The fixed-price contract has a ceiling value of $1,489.87 and an ultimate completion date of April 1, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,000 units of the medication Tamsulosin Hydrochloride 0.4 mg capsule, with a ceiling value of $11,118.38. The contract is a firm fixed-price delivery order with a completion date of January 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FWS85
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp for the supply of 1,000 units of the medication Tamsulosin Hydrochloride 0.4 mg capsules. The contract has a firm fixed price of $1,484.94 and an ultimate completion date of August 22, 2024. It is not designated as a set-aside contract. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award, which is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a range of medical commodities, including prescription drugs, to support military treatment programs and facilities worldwide.

Generated 11/20/24, 9:03 AM